Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

• Hoofdauteurs: Kei Irie (Auteur), Atsushi Nakagawa (Auteur), Hirotoshi Fujita (Auteur), Ryo Tamura (Auteur), Masaaki Eto (Auteur), Hiroaki Ikesue (Auteur), Nobuyuki Muroi (Auteur), Keisuke Tomii (Auteur), Tohru Hashida (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wiley, 2020-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Since December 2019, a novel coronavirus (severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)) infection has been rapidly spreading worldwide and causing the respiratory illness, coronavirus disease 2019 (COVID‐19). The antiretroviral drug favipiravir (FPV) has been experimentally used for...